Our data showed that silencing the NCAPH gene combined with everolimus or flavonoids significantly inhibits the malignant progression of PCa cells in vitro and in vivo and is superior to everolimus or flavonoids alone. The gene discussed is NCAPH; the disease is posterior cortical atrophy.